TickerFacts.

RxSight, Inc. (RXST): Operating Income

Annual figures by period end, from SEC filings.

-$48.19M
Year ended 2025-12-31
-$55.11M
Trailing 12 months to 2026-06-30
2020-12-31: -$35.41M2021-12-31: -$52.79M2022-12-31: -$63.32M2023-12-31: -$50.09M2024-12-31: -$36.86M2025-12-31: -$48.19M-$48.19M
2020-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31-$48.19Mn/m2026-02-25, From 2025-01-01
2024-12-31-$36.86Mn/m2026-02-25, From 2024-01-01
2023-12-31-$50.09Mn/m2026-02-25, From 2023-01-01
2022-12-31-$63.32Mn/m2025-02-25, From 2022-01-01
2021-12-31-$52.79Mn/m2023-03-06, From 2021-01-01
2020-12-31-$35.41Mn/a2022-03-08, From 2020-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Ophthalmic Goods), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
RxSight, Inc. (RXST)2025-12-31-$48.19Mn/m
Staar Surgical Co (STAA)2026-01-02-$91.71Mn/m
Warby Parker Inc. (WRBY)2025-12-31-$5.34Mn/m
National Vision Holdings, Inc. (EYE)2026-01-03$58.83Mn/m
Cooper Companies, Inc. (COO)2025-10-31$682.90M-3.2%
Bausch & Lomb Corp (BLCO)2025-12-31$113.00M-30.2%

Compare RXST, STAA, WRBY, EYE side by side · Screen every company in Ophthalmic Goods ↗